Tag: Clinical Trial
Human stem cell treatment restores motor function in paralyzed rats
Rats paralyzed due to loss of blood flow to the spine returned to near normal ambulatory function six weeks after receiving grafts of human...
Patients heading abroad for hope
Those with spinal injuries brave risks to find new therapies overseas
McKINNEY – Two weeks after Tonya Winchester celebrated her high school graduation, an 18-wheeler...
Q Therapeutics Wins Biotechnology Innovation Award for 2007
SALT LAKE CITY--(BUSINESS WIRE)--Q Therapeutics, Inc. announced today that it has been awarded the 2007 Utah Innovation Award for Biotechnology/Pharmaceuticals. The award honors Q's...
Adventurer’s next step is to take his first step
It WOULD never have happened if they had just stuck to the plan. But the £8 ($A19) air fares were too good to ignore....
Neurostimulation Comes of Age
Millions of people worldwide live active lives, thanks to implanted pacemakers that deliver electrical impulses to restore normal function to the heart. Now, electrical...
Embryonic stem cells trial on track to start
The first clinical trial of embryonic stem cells is on track to start early next year on patients with spinal cord injury. Geron (NASDAQ:GERN...
Analysis: Stem cells closer to trials
WASHINGTON, May 9 (UPI) -- Despite the limitations on federal funding for embryonic stem cell research, two companies recently said they are close to...
Q Therapeutics Announces New Stem Cell Patent
SALT LAKE CITY--(BUSINESS WIRE)--Q Therapeutics, Inc. announced today that it was awarded Patent Number 7,214,372, titled "Methods Using Lineage Restricted Glial Precursors from the...
Stem cell research center opens ‘doors of possibility’
PISCATAWAY -- It looked empty, but the first piece of New Jersey's new stem cell research center filled Saturday with the hopes and expectations...
Cyberkinetics Provides Andara(TM) OFS(TM) Therapy for Spanish Motorcycle Racer with Spinal Cord Injury
FOXBOROUGH, Mass.--(BUSINESS WIRE)--Cyberkinetics Neurotechnology Systems, Inc. (OTCBB: CYKN; "Company"; "Cyberkinetics"), announced that the Company provided its Andara(TM) Oscillating Field Stimulator (OFS(TM)) System to a...
